Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.06.2017 | case report | Ausgabe 2/2017

memo - Magazine of European Medical Oncology 2/2017

Primary signet cell carcinoma of the prostate: a case report

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 2/2017
Autoren:
Mustafa Sungur, Aykut Buğra Şentürk, Selahattin Çalışkan, Abdullah Gürel

Summary

Primary signet cell carcinoma of the prostate is very rare histological variant and usually originates from the stomach, colon, and pancreas. This malignancy was first reported in 1979 and there have been case series with small numbers of patients and case reports in the literature. Signet cell carcinoma of the prostate has a poor outcome when compared to classic prostate adenocarcinoma. A case of primary signet cell carcinoma of the prostate that was treated with maximal androgen deprivation therapy with zoledronic acid is reported.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2017

memo - Magazine of European Medical Oncology 2/2017 Zur Ausgabe